Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 2 hours ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

Press ReleaseBipartisan2026-09-15

McBath Introduces Bipartisan Bill to Increase Transparency in Prescription Drug Market

Lucy McBath
Lucy McBath
DGA-6 · Representative
Share:
Healthcare

Context

This press release from Representative Lucy McBath (D-GA) was published on 2026-09-15 and titled "McBath Introduces Bipartisan Bill to Increase Transparency in Prescription Drug Market".

Full Text

McBath Introduces Bipartisan Bill to Increase Transparency in Prescription Drug Market

Washington, DC — This week, Congresswoman Lucy McBath (GA-06) introduced the bipartisan Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026, legislation to increase transparency and competition in the pharmacy benefit manager (PBM) market and help lower prescription drug costs. The bill is co-led by Representatives Ryan Mackenzie (PA-07), Jake Auchincloss (MA-04), Rick Allen [ ]
View original source →